218 related articles for article (PubMed ID: 20023593)
1. The effect of acquisition time on visual and semi-quantitative analysis of F-18 FDG-PET studies in patients with head and neck cancer.
Goethals I; D'Asseler Y; Dobbeleir A; Deblaere K; Ham H
Nucl Med Commun; 2010 Mar; 31(3):227-31. PubMed ID: 20023593
[TBL] [Abstract][Full Text] [Related]
2. Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.
Hartung-Knemeyer V; Beiderwellen KJ; Buchbender C; Kuehl H; Lauenstein TC; Bockisch A; Poeppel TD
Invest Radiol; 2013 May; 48(5):290-4. PubMed ID: 23399811
[TBL] [Abstract][Full Text] [Related]
3. The impact of acquisition time on image quality in whole-body 18F-FDG PET/CT for cancer staging.
Hausmann D; Dinter DJ; Sadick M; Brade J; Schoenberg SO; Büsing K
J Nucl Med Technol; 2012 Dec; 40(4):255-8. PubMed ID: 23071347
[TBL] [Abstract][Full Text] [Related]
4. Investigation of 18F-FDG 3D mode PET image quality versus acquisition time.
Brown C; Dempsey MF; Gillen G; Elliott AT
Nucl Med Commun; 2010 Mar; 31(3):254-9. PubMed ID: 20032801
[TBL] [Abstract][Full Text] [Related]
5. High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.
Okamoto S; Shiga T; Yasuda K; Ito YM; Magota K; Kasai K; Kuge Y; Shirato H; Tamaki N
J Nucl Med; 2013 Feb; 54(2):201-7. PubMed ID: 23321456
[TBL] [Abstract][Full Text] [Related]
6. Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability.
Halpern BS; Dahlbom M; Quon A; Schiepers C; Waldherr C; Silverman DH; Ratib O; Czernin J
J Nucl Med; 2004 May; 45(5):797-801. PubMed ID: 15136629
[TBL] [Abstract][Full Text] [Related]
7. Towards fast whole-body PET/MR: Investigation of PET image quality versus reduced PET acquisition times.
Lindemann ME; Stebner V; Tschischka A; Kirchner J; Umutlu L; Quick HH
PLoS One; 2018; 13(10):e0206573. PubMed ID: 30376583
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of normal FDG uptake in palatine tonsil and its potential value for detecting occult head and neck cancers: a PET CT study.
Wong WL; Gibson D; Sanghera B; Goodchild K; Saunders M
Nucl Med Commun; 2007 Sep; 28(9):675-80. PubMed ID: 17667745
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma.
Deantonio L; Beldì D; Gambaro G; Loi G; Brambilla M; Inglese E; Krengli M
Radiat Oncol; 2008 Sep; 3():29. PubMed ID: 18801181
[TBL] [Abstract][Full Text] [Related]
10. Positron Emission Mammography Image Interpretation for Reduced Image Count Levels.
MacDonald LR; Hippe DS; Bender LC; Cotter EW; Voria PR; Hallam PS; Wang CL; Haseley DR; Kelly MM; Parikh JR; Beatty JD; Rogers JV
J Nucl Med; 2016 Mar; 57(3):348-54. PubMed ID: 26635337
[TBL] [Abstract][Full Text] [Related]
11. The assessment of time-of-flight on image quality and quantification with reduced administered activity and scan times in 18F-FDG PET.
Armstrong IS; James JM; Williams HA; Kelly MD; Matthews JC
Nucl Med Commun; 2015 Jul; 36(7):728-37. PubMed ID: 25757197
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of optimal acquisition duration or injected activity for pediatric 18F-FDG PET/CT.
Alessio AM; Sammer M; Phillips GS; Manchanda V; Mohr BC; Parisi MT
J Nucl Med; 2011 Jul; 52(7):1028-34. PubMed ID: 21680684
[TBL] [Abstract][Full Text] [Related]
13. Multi-site quality and variability analysis of 3D FDG PET segmentations based on phantom and clinical image data.
Beichel RR; Smith BJ; Bauer C; Ulrich EJ; Ahmadvand P; Budzevich MM; Gillies RJ; Goldgof D; Grkovski M; Hamarneh G; Huang Q; Kinahan PE; Laymon CM; Mountz JM; Muzi JP; Muzi M; Nehmeh S; Oborski MJ; Tan Y; Zhao B; Sunderland JJ; Buatti JM
Med Phys; 2017 Feb; 44(2):479-496. PubMed ID: 28205306
[TBL] [Abstract][Full Text] [Related]
14. Validation for performing ¹¹C-methionine and ¹⁸F-FDG-PET studies on the same day.
Mitsumoto T; Kubota K; Sato T; Morooka M; Minamimoto R; Shimbo T; Muramatsu Y; Sasaki T; Ito K; Fukushi M
Nucl Med Commun; 2012 Mar; 33(3):297-304. PubMed ID: 22107999
[TBL] [Abstract][Full Text] [Related]
15. Head and neck cancer: dedicated FDG PET/CT protocol for detection--phantom and initial clinical studies.
Yamamoto Y; Wong TZ; Turkington TG; Hawk TC; Coleman RE
Radiology; 2007 Jul; 244(1):263-72. PubMed ID: 17495174
[TBL] [Abstract][Full Text] [Related]
16. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck.
Hustinx R; Smith RJ; Benard F; Rosenthal DI; Machtay M; Farber LA; Alavi A
Eur J Nucl Med; 1999 Oct; 26(10):1345-8. PubMed ID: 10541835
[TBL] [Abstract][Full Text] [Related]
17. Fine needle aspiration diagnosis of benign oncocytic lesions of the head and neck associated with false positive
Hussain M; Ghani H; Ali Y; Clement C; Nawgiri R
Diagn Cytopathol; 2024 Jul; 52(7):387-392. PubMed ID: 38712593
[TBL] [Abstract][Full Text] [Related]
18. Deep Inspiration Breath Hold [(18)F]FDG PET-CT on 4-rings scanners in evaluating lung lesions: evidences from a phantom and a clinical study.
Caobelli F; Puta E; Kaiser SR; Massetti V; Andreoli M; Mostarda A; Soffientini A; Pizzocaro C; Guerra UP
Rev Esp Med Nucl Imagen Mol; 2014; 33(3):136-47. PubMed ID: 24268841
[TBL] [Abstract][Full Text] [Related]
19. Two-dimensional vs three-dimensional imaging in whole body oncologic PET/CT: a Discovery-STE phantom and patient study.
Bettinardi V; Mancosu P; Danna M; Giovacchini G; Landoni C; Picchio M; Gilardi MC; Savi A; Castiglioni I; Lecchi M; Fazio F
Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):214-23. PubMed ID: 17464266
[TBL] [Abstract][Full Text] [Related]
20. Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study.
Halpern BS; Dahlbom M; Auerbach MA; Schiepers C; Fueger BJ; Weber WA; Silverman DH; Ratib O; Czernin J
J Nucl Med; 2005 Apr; 46(4):603-7. PubMed ID: 15809482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
